Join
Live feed
·
INSIDERFilingvia Quantisnow
PTC Therapeutics Inc. logo

EXEC. VP AND CLO Boulding Mark Elliott was granted 17,000 shares, exercised 2,266 shares at a strike of $39.42 and sold $171,192 worth of shares (2,266 units at $75.55), increasing direct ownership by 16% to 120,901 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTCT (PTC Therapeutics Inc.) and more on Quantisnow.